141 related articles for article (PubMed ID: 22271700)
1. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
Morra M; Silander O; Calpe S; Choi M; Oettgen H; Myers L; Etzioni A; Buckley R; Terhorst C
Blood; 2001 Sep; 98(5):1321-5. PubMed ID: 11520777
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.
Lankester AC; Visser LF; Hartwig NG; Bredius RG; Gaspar HB; van der Burg M; van Tol MJ; Gross TG; Egeler RM
Bone Marrow Transplant; 2005 Jul; 36(2):99-105. PubMed ID: 15908972
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
[TBL] [Abstract][Full Text] [Related]
5. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
6. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
[TBL] [Abstract][Full Text] [Related]
7. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
8. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
[TBL] [Abstract][Full Text] [Related]
9. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
[TBL] [Abstract][Full Text] [Related]
11. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.
Sandlund JT; Shurtleff SA; Onciu M; Horwitz E; Leung W; Howard V; Rencher R; Conley ME
Pediatr Blood Cancer; 2013 Sep; 60(9):E85-7. PubMed ID: 23589280
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis.
Kanegane H; Yang X; Zhao M; Yamato K; Inoue M; Hamamoto K; Kobayashi C; Hosono A; Ito Y; Nakazawa Y; Terui K; Kogawa K; Ishii E; Sumazaki R; Miyawaki T
Pediatr Allergy Immunol; 2012 Aug; 23(5):488-93. PubMed ID: 22433061
[TBL] [Abstract][Full Text] [Related]
14. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
[TBL] [Abstract][Full Text] [Related]
15. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
16. A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature.
Eckrich MJ; Yang E; Domm J; Ho R; Calder C; Manes B; Bleesing J; Frangoul H
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e39-42. PubMed ID: 20975587
[TBL] [Abstract][Full Text] [Related]
17. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
[TBL] [Abstract][Full Text] [Related]
18. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.
Gray PE; O'Brien TA; Wagle M; Tangye SG; Palendira U; Roscioli T; Choo S; Sutton R; Ziegler JB; Frith K
J Clin Immunol; 2015 Oct; 35(7):604-9. PubMed ID: 26433589
[TBL] [Abstract][Full Text] [Related]
20. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
